For patients with severe or irreversible moderate mitral regurgitation, NaviGate Cardiac Structures Inc. is developing a catheter-guided compressible valved stent that fits within the diseased mitral valve in a beating heart.

In this month's issue of Start-Up, we profile Alcresta Pharmaceuticals, Gordian Surgical, International Biomedical Devices, NaviGate Cardiac Structures, ObsEva and SweetBio.

Global pharmaceutical firms can look no further than across the Taiwan Strait when working to get products approved and launched in China faster.

The Melbourne biotech firm Cytopia is challenging a merger between the Australian biotechs Progen Pharmaceuticals and Avexa, saying it can offer a better deal to Progen shareholders.